Formerly Riedl
Sharma S, Batra R, Yang SC, Hillinger S, Zhu L, Atianzar K, Strieter R, Riedl K, Huang M, Dubinett SM. IL-7 Gene Modified Dendritic Cells Reduce Pulmonary Tumor Burden in Spontaneous Murine Bronchoalveolar Cell Carcinoma. Human Gene Ther 2003; 14:1511-1524.
Riedl K, Baratelli F, Batra R, Yang SC, Luo J, Escuadro B, Figlin R, Strieter R, Sharma S, Dubinett S. Overexpression of CCL-21/Secondary Lymphoid Tissue Chemokine in Human Monocyte-Derived Dendritic Cells Augments Chemotactic Activities for Lymphocytes and Antigen Presenting Cells. Molecular Cancer 2003; 2:35.
Yang SC, Hillinger S, Riedl K, Zhang L, Zhu L, Huang M, Atianzar K, Kuo BY, Gardner B, Batra RK, Strieter RM, Dubinett SM, Sharma S. Intratumoral Administration of Dendritic Cells Overexpressing CCL21 Generates Systemic Antitumor Responses and Confers Tumor Immunity. Clin Cancer Res 2004; 10:2891-901.
Riedl K, Krysan K, Põld M, Dalwadi H, Heuze-Vourc'h N, Dohadwala M, Liu M, Cui X, Figlin R, Mao JT, Strieter R, Sharma S, Dubinett S. Multifaceted Roles of Cyclooxygenase-2 in Lung Cancer. Drug Resist Update 2004; 7:169-184.
Põld M, Krysan K, Põld A, Dohadwala M, Heuze-Vourc’h N, Mao JT, Riedl KL, Sharma S, Dubinett SM. Cyclooxygenase-2 (COX-2) Modulates The Insulin-like Growth Factor (IGF)-axis in Non-Small Cell Lung Cancer (NSCLC). Cancer Res 2004; 64:6549-6555.
Baratelli FE, Heuze-Vourc’h N, Krysan K, Dohadwala M, Riedl K, Sharma S, Dubinett SM. Prostaglandin E2-Dependent Enhancement of Tissue Inhibitors of Metalloproteinases-1 Production Limits Dendritic Cell Migration through Extracellular Matrix. J Immunol 2004; 173: 5458-5466.
Baratelli F, Krysan K, Heuze-Vourc’h N, Zhu L, Escuadro B, Sharma S, Reckamp K, Dohadwala M, Dubinett SM. PGE2 confers survivin dependent apoptosis resistance in human monocyte-derived dendritic cells. J Leukocyte Bio. 2005; 78: 555-564.
Sharma S, Yang SC, Zhu L, Reckamp K, Gardner B, Baratelli F, Zhang L, Huang M, Batra RK, Dubinett SM. Tumor COX-2/PGE2 dependent promotion of FOXP3 expression and CD4+CD25+ T regulatory cell activities in lung cancer. Cancer Res. 2005; 65: 5211-5220.
Sharma S, Zhu L, Hillinger S, Yang SC, Atianzar K, Gardner B, Kuo B, Reckamp K, Strieter RM, Batra RK, Huang M, Dubinett SM. COX-2 inhibition promotes IFN-dependent enhancement of anti-tumor immunity. J Immunol. 2005; 175: 813-819.
Krysan K, Reckamp KL, Harnisha Dalwadi, Sharma S, Dohadwala M, Dubinett SM. PGE2 activates MAPK/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an EGF receptor-independent manner. Cancer Res 2005; 65: 6275-6281.
Mao JT, Cui X, Reckamp K, Liu M, Krysan K, Dalwadi H, Sharma S, Hazra S, Strieter RM, Gardner B, Dubinett SM. Chemoprevention strategies with cyclooxygenase-2 inhibitors for lung cancer. Clin Lung Cancer. 2005; 7:30-39.
Baratelli F, Lin Y, Zhu L, Yang SC, Heuzé-Vourc’h N, Zeng G, Reckamp K, Dohadwala M, Sharma S, Dubinett SM. PGE2 induces FOXP3 gene expression and T regulatory function in human CD4+ T cells. J Immunol. 2005 175:1483-90.
Mestas J, Burdick MD, Reckamp K, Pantuck A, Figlin RA, Strieter RM. The role of CXCR2/CXCR2 ligand biological axis in renal cell carcinoma. J Immunol 2005 175:5351-5357.
Suh R, Reckamp K, Zeidler M, Cameron R. Radiofrequency ablation in lung cancer: promising results in safety and efficacy. Oncology (Williston Park). 2005 Oct;19(11 Suppl 4):12-21.
Yang SC, Batra RJ, Hillinger S, Reckamp KL, Strieter RM, Dubinett SM, Sharma S. Intrapulmonary Administration of CCL21 Gene-Modified Dendritic Cells Reduces Tumor Burden in Spontaneous Murine Bronchoalveolar Cell Carcinoma. Cancer Res 2006; 66:3205-13.
Krysan K, Reckamp KL, Sharma S, Dubinett SM. The potential and rationale for COX-2 inhibitors in lung cancer. Anticancer Agents Med Chem 2006; 6:209-20.
Reckamp KL, Krysan K, Morrow JD, Newman RA, Tucker C, Elashoff RM, Dubinett SM, Figlin RA. A Phase I Trial to Determine the Optimal Biologic Dose of Celecoxib When Combined with Erlotinib in Advanced Non-Small Cell Lung Cancer. Clin Cancer Res 2006; 12:3381-8.
Pan J, Mestas J, Burdick MD, Phillips RJ, Thomas GV, Reckamp K, Belperio JA, Strieter RM. Stromal Derived Factor-1 (SDF-1/CXCL12) and CXCR4 in Renal Cell Carcinoma Metastasis. Molecular Cancer 2006 5:56.
This is a partial list. Full publications list available upon request. Information on this page may be self-reported and is subject to change at any time. Last updated: 07/08.